Validation pour Ingenuity290

vers la météo de la validation par utilisateur

Ingenuity290

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 45 - PMID ?

In primary culture adipocytes from male SP epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of SP NODE mRNA .

name="reponse" value="NA"> Non annotée
name="reponse" value="JSP"> Je ne sais pas
name="reponse" value="INS"> Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

<?php echo $Com ; ?>

name="reponse" value="A0">Analyse 0

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                                            +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+        +---MOD_ATT:N-N--+                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            +MOD_A+        |        +MOD_ATT+---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A1">Analyse 1

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                                            +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+        +---MOD_ATT:N-N--+                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            +MOD_A+        |        +MOD_ATT+---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A2">Analyse 2

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                                            +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+--COMP:N-N(from)--+        +---MOD_ATT:N-N--+                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            +MOD_A+        |        +MOD_ATT+---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A3">Analyse 3

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                                            +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+--COMP:N-N(from)--+        +---MOD_ATT:N-N--+                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            +MOD_A+        |        +MOD_ATT+---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A4">Analyse 4

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +-------COMP:N-N(from)------+                +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            +-MOD_ATT:N-ADJ+                |                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     +MOD_ATT:+        +MOD_ATT+---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,epididymis)
MOD_ATT:N-ADJ (epididymis,male)
MOD_ATT:N-ADJ (epididymis,__SP__)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A5">Analyse 5

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +-------COMP:N-N(from)------+                +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            +-MOD_ATT:N-ADJ+                |                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     +MOD_ATT:+        +MOD_ATT+---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,epididymis)
MOD_ATT:N-ADJ (epididymis,male)
MOD_ATT:N-ADJ (epididymis,__SP__)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A6">Analyse 6

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                  +-------------------------------------COMP:V-N(from)------------------------------------+                                                           
                         |                  |                         +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+                  |        +---MOD_ATT:N-N--+                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            +MOD_A+        |        +MOD_ATT+---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A7">Analyse 7

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                  +-------------------------------------COMP:V-N(from)------------------------------------+                                                           
                         |                  |                         +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+                  |        +---MOD_ATT:N-N--+                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            +MOD_A+        |        +MOD_ATT+---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A8">Analyse 8

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                  +-------------------------------------COMP:V-N(from)------------------------------------+                                                           
                         |                  |                         +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+                  |        +---MOD_ATT:N-N--+                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            +MOD_A+        |        +MOD_ATT+---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A9">Analyse 9

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                  +-------------------------------------COMP:V-N(from)------------------------------------+                                                           
                         |                  |                         +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+                  |        +---MOD_ATT:N-N--+                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            +MOD_A+        |        +MOD_ATT+---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A10">Analyse 10

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +-----------COMP:N-N(from)-----------+                                                                     |                                                           
                         |            +-----MOD_ATT:N-ADJ-----+       +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            |     +--MOD_ATT:N-ADJ--+       |                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        +MOD_ATT:+       +---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,adipose)
MOD_ATT:N-ADJ (adipose,male)
MOD_ATT:N-ADJ (adipose,__SP__)
MOD_ATT:N-N (adipose,epididymis)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A11">Analyse 11

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +-----------COMP:N-N(from)-----------+                                                                     |                                                           
                         |            +-----MOD_ATT:N-ADJ-----+       +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            |     +--MOD_ATT:N-ADJ--+       |                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        +MOD_ATT:+       +---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,adipose)
MOD_ATT:N-ADJ (adipose,male)
MOD_ATT:N-ADJ (adipose,__SP__)
MOD_ATT:N-N (adipose,epididymis)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A12">Analyse 12

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                           +--------------------------------COMP:V-N(from)--------------------------------+                                                           
                         |                           |                +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            +-MOD_ATT:N-ADJ+                |                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     +MOD_ATT:+        +MOD_ATT+---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-ADJ (epididymis,male)
MOD_ATT:N-ADJ (epididymis,__SP__)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,epididymis)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A13">Analyse 13

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                           +--------------------------------COMP:V-N(from)--------------------------------+                                                           
                         |                           |                +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            +-MOD_ATT:N-ADJ+                |                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     +MOD_ATT:+        +MOD_ATT+---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-ADJ (epididymis,male)
MOD_ATT:N-ADJ (epididymis,__SP__)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,epididymis)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A14">Analyse 14

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                                    +----------------------------COMP:V-N(from)---------------------------+                                                           
                         |            +-----MOD_ATT:N-ADJ-----+       +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            |     +--MOD_ATT:N-ADJ--+       |                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        +MOD_ATT:+       +---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-ADJ (adipose,male)
MOD_ATT:N-ADJ (adipose,__SP__)
MOD_ATT:N-N (adipose,epididymis)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,adipose)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A15">Analyse 15

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                                    +----------------------------COMP:V-N(from)---------------------------+                                                           
                         |            +-----MOD_ATT:N-ADJ-----+       +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            |     +--MOD_ATT:N-ADJ--+       |                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        +MOD_ATT:+       +---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-ADJ (adipose,male)
MOD_ATT:N-ADJ (adipose,__SP__)
MOD_ATT:N-N (adipose,epididymis)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,adipose)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A16">Analyse 16

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +---------------COMP:N-N(from)---------------+                                                             |                                                           
                         |            +---------MOD_ATT:N-ADJ---------+                                                             |                                                           
                         |            |     +------MOD_ATT:N-ADJ------+          +---------------------SUBJ:V-N---------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            |     |        +---MOD_ATT:N-N--+          |                            +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        |        +MOD_ATT+          |                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,toilet)
MOD_ATT:N-ADJ (toilet,male)
MOD_ATT:N-ADJ (toilet,__SP__)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,bezafibrate)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A17">Analyse 17

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +---------------COMP:N-N(from)---------------+                                                             |                                                           
                         |            +---------MOD_ATT:N-ADJ---------+                                                             |                                                           
                         |            |     +------MOD_ATT:N-ADJ------+          +---------------------SUBJ:V-N---------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            |     |        +---MOD_ATT:N-N--+          |                            +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        |        +MOD_ATT+          |                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,toilet)
MOD_ATT:N-ADJ (toilet,male)
MOD_ATT:N-ADJ (toilet,__SP__)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,bezafibrate)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A18">Analyse 18

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |            +---------MOD_ATT:N-ADJ---------+------------------------COMP:V-N(from)-----------------------+                                                           
                         |            |     +------MOD_ATT:N-ADJ------+          +---------------------SUBJ:V-N---------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            |     |        +---MOD_ATT:N-N--+          |                            +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        |        +MOD_ATT+          |                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-ADJ (toilet,male)
MOD_ATT:N-ADJ (toilet,__SP__)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,toilet)
SUBJ:V-N (decrease,bezafibrate)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A19">Analyse 19

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |            +---------MOD_ATT:N-ADJ---------+------------------------COMP:V-N(from)-----------------------+                                                           
                         |            |     +------MOD_ATT:N-ADJ------+          +---------------------SUBJ:V-N---------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            |     |        +---MOD_ATT:N-N--+          |                            +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        |        +MOD_ATT+          |                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-ADJ (toilet,male)
MOD_ATT:N-ADJ (toilet,__SP__)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,toilet)
SUBJ:V-N (decrease,bezafibrate)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A20">Analyse 20

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +-------COMP:N-N(from)------+                +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            +--MOD_ATT:N-N-+                |                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     +MOD_ATT:+        +MOD_ATT+---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,epididymis)
MOD_ATT:N-N (epididymis,male)
MOD_ATT:N-ADJ (epididymis,__SP__)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A21">Analyse 21

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +-------COMP:N-N(from)------+                +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            +--MOD_ATT:N-N-+                |                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     +MOD_ATT:+        +MOD_ATT+---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,epididymis)
MOD_ATT:N-N (epididymis,male)
MOD_ATT:N-ADJ (epididymis,__SP__)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A22">Analyse 22

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                                            +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+        +---MOD_ATT:N-N--+                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            +MOD_A+        |        +MOD_ATT+---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A23">Analyse 23

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                                            +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+--COMP:N-N(from)--+        +---MOD_ATT:N-N--+                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            +MOD_A+        |        +MOD_ATT+---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A24">Analyse 24

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                                            +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+--COMP:N-N(from)--+        +---MOD_ATT:N-N--+                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            +MOD_A+        |        +MOD_ATT+---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A25">Analyse 25

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                                            +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+--COMP:N-N(from)--+        +---MOD_ATT:N-N--+                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            +MOD_A+        |        +MOD_ATT+---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A26">Analyse 26

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +-----------COMP:N-N(from)-----------+                                                                     |                                                           
                         |            +------MOD_ATT:N-N------+       +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            |     +--MOD_ATT:N-ADJ--+       |                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        +MOD_ATT:+       +---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,adipose)
MOD_ATT:N-N (adipose,male)
MOD_ATT:N-ADJ (adipose,__SP__)
MOD_ATT:N-N (adipose,epididymis)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A27">Analyse 27

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +-----------COMP:N-N(from)-----------+                                                                     |                                                           
                         |            +------MOD_ATT:N-N------+       +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            |     +--MOD_ATT:N-ADJ--+       |                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        +MOD_ATT:+       +---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,adipose)
MOD_ATT:N-N (adipose,male)
MOD_ATT:N-ADJ (adipose,__SP__)
MOD_ATT:N-N (adipose,epididymis)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A28">Analyse 28

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                           +--------------------------------COMP:V-N(from)--------------------------------+                                                           
                         |                           |                +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            +--MOD_ATT:N-N-+                |                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     +MOD_ATT:+        +MOD_ATT+---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-N (epididymis,male)
MOD_ATT:N-ADJ (epididymis,__SP__)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,epididymis)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A29">Analyse 29

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                           +--------------------------------COMP:V-N(from)--------------------------------+                                                           
                         |                           |                +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            +--MOD_ATT:N-N-+                |                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     +MOD_ATT:+        +MOD_ATT+---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-N (epididymis,male)
MOD_ATT:N-ADJ (epididymis,__SP__)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,epididymis)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A30">Analyse 30

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +-------COMP:N-N(from)------+                +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            +-MOD_ATT:N-ADJ+                |                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     +MOD_ATT:+        +MOD_ATT+---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,epididymis)
MOD_ATT:N-ADJ (epididymis,male)
MOD_ATT:N-ADJ (epididymis,__SP__)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A31">Analyse 31

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +-------COMP:N-N(from)------+                +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            +-MOD_ATT:N-ADJ+                |                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     +MOD_ATT:+        +MOD_ATT+---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,epididymis)
MOD_ATT:N-ADJ (epididymis,male)
MOD_ATT:N-ADJ (epididymis,__SP__)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A32">Analyse 32

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                  +-------------------------------------COMP:V-N(from)------------------------------------+                                                           
                         |                  |                         +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+                  |        +---MOD_ATT:N-N--+                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            +MOD_A+        |        +MOD_ATT+---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A33">Analyse 33

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                  +-------------------------------------COMP:V-N(from)------------------------------------+                                                           
                         |                  |                         +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+                  |        +---MOD_ATT:N-N--+                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            +MOD_A+        |        +MOD_ATT+---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A34">Analyse 34

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                  +-------------------------------------COMP:V-N(from)------------------------------------+                                                           
                         |                  |                         +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+                  |        +---MOD_ATT:N-N--+                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            +MOD_A+        |        +MOD_ATT+---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A35">Analyse 35

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                  +-------------------------------------COMP:V-N(from)------------------------------------+                                                           
                         |                  |                         +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+                  |        +---MOD_ATT:N-N--+                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            +MOD_A+        |        +MOD_ATT+---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A36">Analyse 36

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                                    +----------------------------COMP:V-N(from)---------------------------+                                                           
                         |            +------MOD_ATT:N-N------+       +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            |     +--MOD_ATT:N-ADJ--+       |                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        +MOD_ATT:+       +---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-N (adipose,male)
MOD_ATT:N-ADJ (adipose,__SP__)
MOD_ATT:N-N (adipose,epididymis)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,adipose)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A37">Analyse 37

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                                    +----------------------------COMP:V-N(from)---------------------------+                                                           
                         |            +------MOD_ATT:N-N------+       +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            |     +--MOD_ATT:N-ADJ--+       |                                       +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        +MOD_ATT:+       +---APPOS--+                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-N (adipose,male)
MOD_ATT:N-ADJ (adipose,__SP__)
MOD_ATT:N-N (adipose,epididymis)
APPOS (toilet,bezafibrate)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,adipose)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A38">Analyse 38

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +-----------COMP:N-N(from)-----------+                                                                     |                                                           
                         |            +-----MOD_ATT:N-ADJ-----+       +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            |     +--MOD_ATT:N-ADJ--+       |                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        +MOD_ATT:+       +---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,adipose)
MOD_ATT:N-ADJ (adipose,male)
MOD_ATT:N-ADJ (adipose,__SP__)
MOD_ATT:N-N (adipose,epididymis)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A39">Analyse 39

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +-----------COMP:N-N(from)-----------+                                                                     |                                                           
                         |            +-----MOD_ATT:N-ADJ-----+       +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            |     +--MOD_ATT:N-ADJ--+       |                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        +MOD_ATT:+       +---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,adipose)
MOD_ATT:N-ADJ (adipose,male)
MOD_ATT:N-ADJ (adipose,__SP__)
MOD_ATT:N-N (adipose,epididymis)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A40">Analyse 40

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                           +--------------------------------COMP:V-N(from)--------------------------------+                                                           
                         |                           |                +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            +-MOD_ATT:N-ADJ+                |                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     +MOD_ATT:+        +MOD_ATT+---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-ADJ (epididymis,male)
MOD_ATT:N-ADJ (epididymis,__SP__)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,epididymis)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A41">Analyse 41

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                           +--------------------------------COMP:V-N(from)--------------------------------+                                                           
                         |                           |                +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            +-MOD_ATT:N-ADJ+                |                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     +MOD_ATT:+        +MOD_ATT+---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-ADJ (epididymis,male)
MOD_ATT:N-ADJ (epididymis,__SP__)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,epididymis)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A42">Analyse 42

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +---------------COMP:N-N(from)---------------+                                                             |                                                           
                         |            +----------MOD_ATT:N-N----------+                                                             |                                                           
                         |            |     +------MOD_ATT:N-ADJ------+          +---------------------SUBJ:V-N---------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            |     |        +---MOD_ATT:N-N--+          |                            +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        |        +MOD_ATT+          |                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,toilet)
MOD_ATT:N-N (toilet,male)
MOD_ATT:N-ADJ (toilet,__SP__)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,bezafibrate)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A43">Analyse 43

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +---------------COMP:N-N(from)---------------+                                                             |                                                           
                         |            +----------MOD_ATT:N-N----------+                                                             |                                                           
                         |            |     +------MOD_ATT:N-ADJ------+          +---------------------SUBJ:V-N---------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            |     |        +---MOD_ATT:N-N--+          |                            +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        |        +MOD_ATT+          |                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,toilet)
MOD_ATT:N-N (toilet,male)
MOD_ATT:N-ADJ (toilet,__SP__)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,bezafibrate)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A44">Analyse 44

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                                    +----------------------------COMP:V-N(from)---------------------------+                                                           
                         |            +-----MOD_ATT:N-ADJ-----+       +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            |     +--MOD_ATT:N-ADJ--+       |                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        +MOD_ATT:+       +---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-ADJ (adipose,male)
MOD_ATT:N-ADJ (adipose,__SP__)
MOD_ATT:N-N (adipose,epididymis)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,adipose)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A45">Analyse 45

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                                    +----------------------------COMP:V-N(from)---------------------------+                                                           
                         |            +-----MOD_ATT:N-ADJ-----+       +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            |     +--MOD_ATT:N-ADJ--+       |                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        +MOD_ATT:+       +---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-ADJ (adipose,male)
MOD_ATT:N-ADJ (adipose,__SP__)
MOD_ATT:N-N (adipose,epididymis)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,adipose)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A46">Analyse 46

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |            +----------MOD_ATT:N-N----------+------------------------COMP:V-N(from)-----------------------+                                                           
                         |            |     +------MOD_ATT:N-ADJ------+          +---------------------SUBJ:V-N---------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            |     |        +---MOD_ATT:N-N--+          |                            +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        |        +MOD_ATT+          |                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-N (toilet,male)
MOD_ATT:N-ADJ (toilet,__SP__)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,toilet)
SUBJ:V-N (decrease,bezafibrate)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A47">Analyse 47

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |            +----------MOD_ATT:N-N----------+------------------------COMP:V-N(from)-----------------------+                                                           
                         |            |     +------MOD_ATT:N-ADJ------+          +---------------------SUBJ:V-N---------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            |     |        +---MOD_ATT:N-N--+          |                            +COMP:N-N(of+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        |        +MOD_ATT+          |                   +MOD_ATT:+       +MOD+         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |                   |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-N (toilet,male)
MOD_ATT:N-ADJ (toilet,__SP__)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,hour)
MOD_ATT:N-ADJ (hour,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,toilet)
SUBJ:V-N (decrease,bezafibrate)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A48">Analyse 48

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +---------------COMP:N-N(from)---------------+                                                             |                                                           
                         |            +---------MOD_ATT:N-ADJ---------+                                                             |                                                           
                         |            |     +------MOD_ATT:N-ADJ------+          +---------------------SUBJ:V-N---------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            |     |        +---MOD_ATT:N-N--+          |          +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        |        +MOD_ATT+          |          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,toilet)
MOD_ATT:N-ADJ (toilet,male)
MOD_ATT:N-ADJ (toilet,__SP__)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,bezafibrate)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A49">Analyse 49

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +---------------COMP:N-N(from)---------------+                                                             |                                                           
                         |            +---------MOD_ATT:N-ADJ---------+                                                             |                                                           
                         |            |     +------MOD_ATT:N-ADJ------+          +---------------------SUBJ:V-N---------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            |     |        +---MOD_ATT:N-N--+          |          +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        |        +MOD_ATT+          |          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,toilet)
MOD_ATT:N-ADJ (toilet,male)
MOD_ATT:N-ADJ (toilet,__SP__)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,bezafibrate)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A50">Analyse 50

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |            +---------MOD_ATT:N-ADJ---------+------------------------COMP:V-N(from)-----------------------+                                                           
                         |            |     +------MOD_ATT:N-ADJ------+          +---------------------SUBJ:V-N---------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            |     |        +---MOD_ATT:N-N--+          |          +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        |        +MOD_ATT+          |          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-ADJ (toilet,male)
MOD_ATT:N-ADJ (toilet,__SP__)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,toilet)
SUBJ:V-N (decrease,bezafibrate)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A51">Analyse 51

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |            +---------MOD_ATT:N-ADJ---------+------------------------COMP:V-N(from)-----------------------+                                                           
                         |            |     +------MOD_ATT:N-ADJ------+          +---------------------SUBJ:V-N---------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            |     |        +---MOD_ATT:N-N--+          |          +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        |        +MOD_ATT+          |          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-ADJ (toilet,male)
MOD_ATT:N-ADJ (toilet,__SP__)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,toilet)
SUBJ:V-N (decrease,bezafibrate)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A52">Analyse 52

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +-------COMP:N-N(from)------+                +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            +--MOD_ATT:N-N-+                |                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     +MOD_ATT:+        +MOD_ATT+---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,epididymis)
MOD_ATT:N-N (epididymis,male)
MOD_ATT:N-ADJ (epididymis,__SP__)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A53">Analyse 53

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +-------COMP:N-N(from)------+                +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            +--MOD_ATT:N-N-+                |                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     +MOD_ATT:+        +MOD_ATT+---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,epididymis)
MOD_ATT:N-N (epididymis,male)
MOD_ATT:N-ADJ (epididymis,__SP__)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A54">Analyse 54

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +-----------COMP:N-N(from)-----------+                                                                     |                                                           
                         |            +------MOD_ATT:N-N------+       +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            |     +--MOD_ATT:N-ADJ--+       |                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        +MOD_ATT:+       +---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,adipose)
MOD_ATT:N-N (adipose,male)
MOD_ATT:N-ADJ (adipose,__SP__)
MOD_ATT:N-N (adipose,epididymis)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A55">Analyse 55

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +-----------COMP:N-N(from)-----------+                                                                     |                                                           
                         |            +------MOD_ATT:N-N------+       +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            |     +--MOD_ATT:N-ADJ--+       |                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        +MOD_ATT:+       +---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,adipose)
MOD_ATT:N-N (adipose,male)
MOD_ATT:N-ADJ (adipose,__SP__)
MOD_ATT:N-N (adipose,epididymis)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A56">Analyse 56

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                           +--------------------------------COMP:V-N(from)--------------------------------+                                                           
                         |                           |                +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            +--MOD_ATT:N-N-+                |                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     +MOD_ATT:+        +MOD_ATT+---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-N (epididymis,male)
MOD_ATT:N-ADJ (epididymis,__SP__)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,epididymis)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A57">Analyse 57

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                           +--------------------------------COMP:V-N(from)--------------------------------+                                                           
                         |                           |                +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            +--MOD_ATT:N-N-+                |                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     +MOD_ATT:+        +MOD_ATT+---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-N (epididymis,male)
MOD_ATT:N-ADJ (epididymis,__SP__)
MOD_ATT:N-N (toilet,adipose)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,epididymis)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A58">Analyse 58

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                                    +----------------------------COMP:V-N(from)---------------------------+                                                           
                         |            +------MOD_ATT:N-N------+       +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            |     +--MOD_ATT:N-ADJ--+       |                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        +MOD_ATT:+       +---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-N (adipose,male)
MOD_ATT:N-ADJ (adipose,__SP__)
MOD_ATT:N-N (adipose,epididymis)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,adipose)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A59">Analyse 59

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |                                    +----------------------------COMP:V-N(from)---------------------------+                                                           
                         |            +------MOD_ATT:N-N------+       +---------------------------SUBJ:V-N--------------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            |     +--MOD_ATT:N-ADJ--+       |                     +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        +MOD_ATT:+       +---APPOS--+          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-N (adipose,male)
MOD_ATT:N-ADJ (adipose,__SP__)
MOD_ATT:N-N (adipose,epididymis)
APPOS (toilet,bezafibrate)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,adipose)
SUBJ:V-N (decrease,toilet)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A60">Analyse 60

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +---------------COMP:N-N(from)---------------+                                                             |                                                           
                         |            +----------MOD_ATT:N-N----------+                                                             |                                                           
                         |            |     +------MOD_ATT:N-ADJ------+          +---------------------SUBJ:V-N---------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            |     |        +---MOD_ATT:N-N--+          |          +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        |        +MOD_ATT+          |          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,toilet)
MOD_ATT:N-N (toilet,male)
MOD_ATT:N-ADJ (toilet,__SP__)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,bezafibrate)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A61">Analyse 61

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         +---------------COMP:N-N(from)---------------+                                                             |                                                           
                         |            +----------MOD_ATT:N-N----------+                                                             |                                                           
                         |            |     +------MOD_ATT:N-ADJ------+          +---------------------SUBJ:V-N---------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            |     |        +---MOD_ATT:N-N--+          |          +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        |        +MOD_ATT+          |          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
COMP:N-N(from) (adipocytes,toilet)
MOD_ATT:N-N (toilet,male)
MOD_ATT:N-ADJ (toilet,__SP__)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
SUBJ:V-N (decrease,bezafibrate)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A62">Analyse 62

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |            +----------MOD_ATT:N-N----------+------------------------COMP:V-N(from)-----------------------+                                                           
                         |            |     +------MOD_ATT:N-ADJ------+          +---------------------SUBJ:V-N---------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +--MOD_ATT:N-ADJ--+            |     |        +---MOD_ATT:N-N--+          |          +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        |        +MOD_ATT+          |          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-N (toilet,male)
MOD_ATT:N-ADJ (toilet,__SP__)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,toilet)
SUBJ:V-N (decrease,bezafibrate)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

name="reponse" value="A63">Analyse 63

                         +-----------------------------------------------COMP:V-N(In)-----------------------------------------------+                                                           
                         |            +----------MOD_ATT:N-N----------+------------------------COMP:V-N(from)-----------------------+                                                           
                         |            |     +------MOD_ATT:N-ADJ------+          +---------------------SUBJ:V-N---------------------+-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       +---MOD_ATT:N-N---+            |     |        +---MOD_ATT:N-N--+          |          +-----------OBJ:V-N-----------+         +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |       +MOD_ATT:N+            |     |        |        +MOD_ATT+          |          |        +MOD_ATT:+COMP:N-+   |         |           +MOD_+           |           |       +MOD_AT+   
       |       |         |            |     |        |        |       |          |          |        |        |       |   |         |           |    |           |           |       |      |   
 In primary culture adipocytes from male __SP__ epididymis adipose tissue , bezafibrate ( with a treatment period of 24 hours ) decreases ( by 30 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (adipocytes,primary)
MOD_ATT:N-N (adipocytes,culture)
MOD_ATT:N-N (toilet,male)
MOD_ATT:N-ADJ (toilet,__SP__)
MOD_ATT:N-N (toilet,epididymis)
MOD_ATT:N-N (toilet,adipose)
OBJ:V-N (with,hour)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,@card@)
COMP:V-N(In) (decrease,adipocytes)
COMP:V-N(from) (decrease,toilet)
SUBJ:V-N (decrease,bezafibrate)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)